The commercial case for investing in ALS

Brittany Darrow, Priscila Radu and Amanda Cole

Grant-Funded Research from Office of Health Economics

Abstract: Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive neurodegenerative disease with devastating clinical and economic consequences.

JEL-codes: I1 (search for similar items in EconPapers)
Date: 2025-11-13
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/the-commercial-case-for-investing-in-als/ (text/html)
https://www.ohe.org/wp-content/uploads/2025/11/Dar ... investing-in-ALS.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:grafun:002521

Access Statistics for this paper

More papers in Grant-Funded Research from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).